Koji Sasaki, Hagop Kantarjian, Elias Jabbour, Farhad Ravandi, Koichi Takahashi, Marina Konopleva, Gautam Borthakur, Guillermo Garcia-Manero, William Wierda, Naval Daver, Preetesh Jain, Toshihisa Satta, Sherry Pierce, May Beth Rios, and Jorge E. Cortes. 2016. “Frontline Therapy With High-Dose Imatinib Versus Second Generation Tyrosine Kinase Inhibitor in Patients With Chronic-Phase Chronic Myeloid Leukemia – a Propensity Score Analysis”. Haematologica 101 (8). Pavia, Italy, e324-e327. https://doi.org/10.3324/haematol.2015.139089.